1Liu Hui-Rong, Tao Ling, Gao Erhe, et al. Anti-apoptotic effects of rosiglitazom in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion [ J ]. Cardiovase Res, 2004, 62:135-144.
2Wang Tzung-Dan, Chen Wen-Jone, Su SS, et al. Increased cardiomyocyte apoptosis following ischemia and reperfusion in diet-induced hypercholesterolemia: relation to Bcl-2 and Bax proteins and caspase-3 activity[J]. Lipids, 2002, 37: 385 - 394.
2Thiemermann C, Zacharowski K. Selective activation of E-type prostanoid(3)-3 receptors reduces myocardial infarct size: a novel insight into the cardioprotective effects of prostaglandins. Pharmacol Ther, 2000,87:61-67.
3Vanden Hoek T, Becker LB, Shao ZH, et al. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion . Circ Res, 2000,86:541-548.
4Hagar JM, Hale SL, Kloner RA.Effect of preconditioning ischemia on reperfusion arrhythmias after coronary occlusion and reperfusion in the rat. Circ Res, 1991,68:61-68.
5O'Rourke B. Myocardial K(ATP) channels in preconditioning. Circ Res, 2000, 87:845-855.
6Liu HR, Tao L,Gao E, et al. Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc Res, 2004, 62: 135-144.
7Wayman NS, Hattori Y,McDonald MC,et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J, 2002, 16: 1027-1040.
8Higuchi M, Aggarwal BB, Yeh ET. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest, 1997,99: 1751-1758.
9Communal C, Sumandea M, de Tombe P, et al. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A, 2002, 99:6252-6256.
10Chandrashekhar Y, Sen S, Anway R, et al. Long-term Caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol, 2004, 43:295-301.
6Kaplan F, Al-Majali K, Betteridge DJ.PPARS,insulin resistance and type 2 diabetes. J Cardiovasc Risk,2001, 8(4): 211-217.
7Kim H,Haluzik M,Gavrilova O,et al. Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipi-daemia without affecting the hyperglyeaemia in a transgenic model of type 2 diabetes. Diabetologia,2004,47(12): 2215-2225.
10Zingarelli B,Cook JA. Peroxisome proliferactor activated receptor gamma is a new theraoeutic target in sepsis and inflammation. Shock, 2005,23(5): 393-399.
